With a novel technology, around 25 antibodies can now be tested simultaneously in a single mouse. This should speed up the R&D pipeline for new drugs and hugely reduce the number of animals required.
In lupus, the immune system attacks its own structures, causing inflammation and organ damage. A new study shows that natural active ingredient gluconolactone could offer a more targeted therapy.
Detecting prostate cancer at an early stage, keeping transplantation organs viable for longer, or a lab that fits on a chip: these six spin-offs from UZH are bringing research ideas to the market.
Professor Martin Wolf has been awarded one of the coveted SNSF Advanced Grants 2023. His project to develop an imaging device capable of detecting hypoxia in premature babies will receive CHF 1.9 million of funding.